|Application ||WB, E|
|Other Accession||NP_001138423.1, NP_660305.2|
|Calculated MW||55253 Da|
|Antigen Region||107-135 aa|
|Other Names||Glycerate kinase, HBeAg-binding protein 4, GLYCTK, HBEBP4|
|Target/Specificity||This GLYCTK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 107-135 amino acids from the N-terminal region of human GLYCTK.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Precautions||GLYCTK Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Isoform 1: Cytoplasm|
|Tissue Location||Widely expressed.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This locus encodes a member of the glycerate kinase type-2 family. The encoded enzyme catalyzes the phosphorylation of (R)-glycerate and may be involved in serine degradation and fructose metabolism. Decreased activity of the encoded enzyme may be associated with the disease D-glyceric aciduria. Alternatively spliced transcript variants have been described. [provided by RefSeq].
Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009)
Guo, J.H., et al. DNA Seq. 17(1):1-7(2006)
Fontaine, M., et al. Clin. Chem. 35(10):2148-2151(1989)
Van Schaftingen, E. FEBS Lett. 243(2):127-131(1989)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.